Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Sernova Biotherapeutics Inc. (T.SVA) had Earnings per Share (EPS) (Basic) of -0.01 for the most recently reported fiscal quarter, ending 2026-07-31.
| Income Statement Financials | |
-- |
|
-1.81M |
|
-- |
|
-- |
|
-- |
|
-1.52M |
|
-- |
|
-1.84M |
|
-1.84M |
|
-1.81M |
|
-1.81M |
|
-1.81M |
|
-1.81M |
|
-1.52M |
|
-1.51M |
|
377.64M |
|
377.64M |
|
|
Earnings per Share (EPS) (Basic) |
-0.01 |
-0.01 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.27M |
|
-- |
|
-- |
|
-- |
|
8.68M |
|
-17.02M |
|
-8.41M |
|
-8.41M |
|
377.64M |
|
| Cash Flow Statement Financials | |
-3.04M |
|
-- |
|
2.89M |
|
0.19M |
|
0.05M |
|
-0.14M |
|
1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.01 |
|
-0.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.64% |
|
21.52% |
|
-676.25% |
|
21.66% |
|
-0.03 |
|
-0.01 |
|
-0.01 |
|